New radiation method aims to cut bowel problems in bladder cancer patients
NCT ID NCT05295992
First seen Mar 15, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study tests a daily adaptive radiation therapy for muscle-invasive bladder cancer. The goal is to see if this personalized approach reduces diarrhea and other bowel side effects compared to standard radiation. About 110 adults with bladder cancer will participate, and the treatment is tailored each day to target the tumor while sparing healthy tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Herlev and Gentofte Hospital
Herlev, DK-2730, Denmark
Conditions
Explore the condition pages connected to this study.